Literature DB >> 22879357

The prevalence of prenatal opioid and other drug use in Utah.

Karen F Buchi1, Carla Suarez, Michael W Varner.   

Abstract

OBJECTIVES: Determine the prevalence of prenatal opioid and other drug positivity among women delivering infants in Utah and compare the findings with national data. STUDY
DESIGN: Umbilical cord tissue samples and nonidentifiable demographic data were collected anonymously in 13 labor and delivery units throughout Utah. Samples were analyzed for opioids, amphetamines, cannabinoids, cocaine, phencyclidine, barbiturates, benzodiazepines, propoxyphene, and alcohol biomarkers.
RESULTS: Fifty-eight (6.8%) of 850 umbilical cord samples were positive for one or more substances. Opioids were the most frequently detected drugs (4.7%). Fewer samples were positive for alcohol (0.4%), methamphetamine (0.1%), cocaine (0.1%), and marijuana (0.4%).
CONCLUSION: Opioids were the most frequently detected drugs at delivery. Although some of the samples positive for opioids might have been a result of intrapartum exposure, a significant number were positive for opioids that are not given during labor. This parallels the increasing nonmedical use of prescription pain medications in the general population and has important implications for neonates because of the potential for significant morbidity secondary to neonatal abstinence syndrome. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2012        PMID: 22879357     DOI: 10.1055/s-0032-1323586

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  3 in total

1.  Neonatal abstinence syndrome: Effectiveness of targeted umbilical cord drug screening.

Authors:  Alecia J Karr; Mary Kay Rayens; Leslie K Scott
Journal:  J Perinatol       Date:  2022-07-09       Impact factor: 3.225

2.  Dysregulation of inflammatory cytokines and inhibition of VEGFA in the human umbilical cord are associated with negative pregnancy outcomes.

Authors:  Camron Chehroudi; Hugh Kim; Tricia E Wright; Abby C Collier
Journal:  Placenta       Date:  2019-09-03       Impact factor: 3.481

3.  Retrospective analysis of the diagnostic yield of newborn drug testing.

Authors:  Kelly E Wood; Lori L Sinclair; Carolyn D Rysgaard; Frederick G Strathmann; Gwendolyn A McMillin; Matthew D Krasowski
Journal:  BMC Pregnancy Childbirth       Date:  2014-07-29       Impact factor: 3.007

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.